Functional coronary angiography for the assessment of the epicardial vessels and the microcirculation
- PMID: 37326378
- PMCID: PMC10266405
- DOI: 10.4244/EIJ-D-22-00969
Functional coronary angiography for the assessment of the epicardial vessels and the microcirculation
Abstract
Over the last decade, steady progress has been made in the ability to assess coronary stenosis relevance by merging computerised analyses of angiograms with fluid dynamic modelling. The new field of functional coronary angiography (FCA) has attracted the attention of both clinical and interventional cardiologists as it anticipates a new era of facilitated physiological assessment of coronary artery disease, without the need for intracoronary instrumentation or vasodilator drug administration, and an increased adoption of ischaemia-driven revascularisation. This state-of-the-art review performs a deep dive into the foundations and rationale behind FCA indices derived from either invasive or computed angiograms. We discuss the currently available FCA systems, the evidence supporting their use, and the specific clinical scenarios in which FCA might facilitate patient management. Finally, the rapidly growing application of FCA to the diagnosis of coronary microvascular dysfunction is discussed. Overall, we aim to provide a state-of-the-art review not only to digest the achievements made so far in FCA, but also to enable the reader to follow the many publications and developments in this field that will likely take place in years to come.
Conflict of interest statement
H.Mejía-Rentería has received speaker fees from Abbott Vascular, Boston Scientific, and Philips Healthcare. J.M.Lee received aresearch grant from Abbott Vascular and Philips/Volcano. H.Matsuo has received speaker fees from Philips, Boston Scientific, Abbott Vascular, and Zeon Medical. S.Baptista has received personal fees from Abbott, Boston Scientific, and HeartFlow. N.Gonzalo has received consultancy and speaker fees from Abbott Vascular, Boston Scientific, Philips/Volcano, and Shockwave Medical. J.Escaned has received speaker and/or advisory board member fees from Abbott Vascular, Boston Scientific, Medis, and Philips. The other authors have no conflicts of interest to declare.
Figures









References
-
- Marcus ML, Skorton DJ, Johnson MR, Collins SM, Harrison DG, Kerber RE. Visual estimates of percent diameter coronary stenosis: “a battered gold standard”. J Am Coll Cardiol. 1988;11:882–5. - PubMed
-
- Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol. 1974;33:87–94. - PubMed
-
- Wijns W, Serruys PW, Reiber JHC, van den, Simoons ML, Kooijman CJ, Balakumaran K, Hugenholtz PG. Quantitative angiography of the left anterior descending coronary artery: Correlations with pressure gradient and results of exercise thallium scintigraphy. Circulation. 1985;71:273–9. - PubMed
-
- Pijls NH, De Bruyne, Peels K, Van Der, Bonnier HJRM, Bartunek J, Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996;334:1703–8. - PubMed
-
- Tonino PA, De Bruyne, Pijls NH, Siebert U, Ikeno F, van’ t, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee, MacCarthy PA, Fearon WF FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213–24. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical